Federated Hermes
TTPH

Federated Hermes’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Federated Hermes’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-76
Closed -$1K – 2421
2019
Q4 		$1K Buy
+76
New +$244 ﹤0.01% 2186
2019
Q3 		– Sell
-61
Closed -$1K – 2338
2019
Q2 		$1K Sell
61
-216
-78% -$3.98K ﹤0.01% 2140
2019
Q1 		$7K Buy
277
+39
+16% +$993 ﹤0.01% 1937
2018
Q4 		$5K Buy
238
+13
+6% +$508 ﹤0.01% 1990
2018
Q3 		$12K Buy
225
+59
+36% +$3.77K ﹤0.01% 1936
2018
Q2 		$12K Sell
166
-1,634
-91% -$115K ﹤0.01% 1886
2018
Q1 		$110K Sell
1,800
-5,653
-76% -$496K ﹤0.01% 1582
2017
Q4 		$939K Sell
7,453
-407
-5% -$52.1K ﹤0.01% 1240
2017
Q3 		$1.07M Sell
7,860
-2,469
-24% -$330K ﹤0.01% 1182
2017
Q2 		$1.47M Buy
10,329
+2,069
+25% +$320K ﹤0.01% 1067
2017
Q1 		$1.52M Buy
8,260
+1,720
+26% +$193K ﹤0.01% 1019
2016
Q4 		$527K Buy
6,540
+66
+1% +$5.22K ﹤0.01% 1293
2016
Q3 		$496K Buy
6,474
+1,809
+39% +$145K ﹤0.01% 1285
2016
Q2 		$401K Buy
+4,665
New +$427K ﹤0.01% 1337

Other funds holding TTPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Federated Hermes's TTPH Position: Q1 2020 in Review

Federated Hermes sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2020, closing a stake of 76 shares — an estimated $1K sold.

Federated Hermes first reported a position in TTPH in Q2 2016 and held it in 14 quarters. The position peaked at $1.52M in Q1 2017. 25 funds tracked by Wall St. Rank hold TTPH as of Q1 2020.

  • Federated Hermes reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Federated Hermes sold 76 Tetraphase Pharmaceuticals, Inc. shares in Q1 2020, an estimated $1K.
  • Federated Hermes first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2016 and held it in 14 quarters.
  • Federated Hermes's Tetraphase Pharmaceuticals, Inc. position peaked at $1.52M in Q1 2017.
  • 25 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2020.

Based on Federated Hermes's 13F filing for Q1 2020, filed 13 May 2020.